Christopher Hite
Chairman of Partnering & InvestmentsMr. Christopher Hite, also known as Chris, has been Independent Director of Vera Therapeutics Inc. since March 2026. He serves as Independent Non-Employee Director at Kailera Therapeutics, Inc. since May 2025. He serves as Chairman of Partnering & Investments at Royalty Pharma plc since March 2026. He serves as Director of Acceleron Pharma Inc. since June 2020. He serves as Executive Vice President & Vice Chairman of the Board at RP Management, LLC since 2020. He served as Executive Vice President & Vice Chairman at Royalty Pharma plc since April 2020 and he joined Royalty Pharma in March 2020. He joined RP Management in March 2020. He served as Co-Head of Global Healthcare Investment Banking in 2008 and Managing Director at Citigroup Inc. (formerly known as Citigroup Global Markets Australia), Inc. He served as Vice Chairman of Banking, Capital Markets and Advisory (BCMA) at Citi. Mr. Hite served at UBS Group AG, Lehman Brothers Inc. and Merrill Lynch & Co., Inc. Mr. Hite was Vice Chairman and Global Head of Healthcare at Citibank, where he worked from 2008 to March 2020. Mr. Hite was Global Head of Healthcare Investment Banking at Lehman Brothers. He is a Member of the FasterCures Board, a center of the Milken Institute. Mr. Hite serves on the Board of Advisors of Faster Cures, a center of the Milken Institute. He has worked with biopharmaceutical companies, including Roche, GSK, Shire, Johnson & Johnson, Celgene, Gilead, Astellas and Tesaro. He served as Managing Director and Head of East Coast healthcare investment banking since February 2007. He holds a Bachelor of Science in Finance from Lehigh University from 1985 to 1989 and a JD & MBA from the University of Pittsburgh.
Positions
- Company NameRoyalty Pharma plcStock CodeRPRXPositionChairman of Partnering & InvestmentsColleagues
- PLPablo LegorretaFounder, Chairman of the Board & CEO
- TPTerrance P. CoyneExecutive VP & CFO
- CHChristopher HiteChairman of Partnering & Investments
- MJMarshall Jonathan UristHead of Research & Investments
- GBGreg Butz Executive Vice President of Partnering & Investments
- GNGregory NordenIndependent Director
- TWTed W. LoveLead Independent Director
- DCDavid Charles HodgsonIndependent Director
- BLBonnie L. BasslerIndependent Director
- Company NameKailera Therapeutics, Inc.Stock CodeKLRAPositionIndependent Non-Employee DirectorColleagues
- RCRonald C. RenaudPresident, CEO & Director
- JFJohn F. MilliganIndependent Non-Employee Chairman
- PDPaul Douglas BurgessChief Operating & Business Officer
- JBJamie Beth ColemanChief Commercial Officer
- DWDouglas W. PaganChief Financial Officer
- MGMaura GavaghanVice President of Corporate Communications & Investor Relations
- ATAndrew T. KaplanIndependent Non-Employee Director
- FKFranklin K. ClyburnIndependent Non-Employee Director
